MA26317A1 - Preparations combinees de derives de 1,1-dioxyde de 1,4-benzothiepine avec d'autres principes actifs et leur utilisation. - Google Patents
Preparations combinees de derives de 1,1-dioxyde de 1,4-benzothiepine avec d'autres principes actifs et leur utilisation.Info
- Publication number
- MA26317A1 MA26317A1 MA27524A MA27524A MA26317A1 MA 26317 A1 MA26317 A1 MA 26317A1 MA 27524 A MA27524 A MA 27524A MA 27524 A MA27524 A MA 27524A MA 26317 A1 MA26317 A1 MA 26317A1
- Authority
- MA
- Morocco
- Prior art keywords
- benzothiepine
- active ingredients
- dioxide derivatives
- combined preparations
- preparations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
- C07D337/02—Seven-membered rings
- C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D337/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Detergent Compositions (AREA)
- Cosmetics (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10140169A DE10140169A1 (de) | 2001-08-22 | 2001-08-22 | Kombinationspräparate von 1,4-Benzothiepin-1,1-dioxidderivaten mit weiteren Wirkstoffen und deren Verwendung |
| DE10142456A DE10142456A1 (de) | 2001-08-31 | 2001-08-31 | Kombinationspräparate von 1,4-Benzothiepin-1,1dioxidderivaten mit weiteren Wirkstoffen und deren Verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA26317A1 true MA26317A1 (fr) | 2004-10-01 |
Family
ID=26009944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA27524A MA26317A1 (fr) | 2001-08-22 | 2004-02-11 | Preparations combinees de derives de 1,1-dioxyde de 1,4-benzothiepine avec d'autres principes actifs et leur utilisation. |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US20030158119A1 (fr) |
| EP (1) | EP1425018B1 (fr) |
| JP (1) | JP2005501861A (fr) |
| KR (1) | KR20040032937A (fr) |
| CN (1) | CN1655792A (fr) |
| AR (1) | AR035285A1 (fr) |
| AT (1) | ATE411802T1 (fr) |
| AU (1) | AU2002333373B2 (fr) |
| BR (1) | BR0212031A (fr) |
| CA (1) | CA2457976A1 (fr) |
| CO (1) | CO5560550A2 (fr) |
| DE (1) | DE50212937D1 (fr) |
| HN (1) | HN2002000235A (fr) |
| HR (1) | HRP20040171A2 (fr) |
| HU (1) | HUP0401318A3 (fr) |
| IL (1) | IL160474A0 (fr) |
| MA (1) | MA26317A1 (fr) |
| MX (1) | MXPA04001328A (fr) |
| NO (1) | NO20040702L (fr) |
| NZ (1) | NZ531293A (fr) |
| OA (1) | OA12654A (fr) |
| PA (1) | PA8553201A1 (fr) |
| PE (1) | PE20030361A1 (fr) |
| PL (1) | PL366851A1 (fr) |
| RS (1) | RS11104A (fr) |
| RU (1) | RU2297222C2 (fr) |
| TN (1) | TNSN04034A1 (fr) |
| UY (1) | UY27419A1 (fr) |
| WO (1) | WO2003018024A1 (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102006053635B4 (de) * | 2006-11-14 | 2011-06-30 | Sanofi-Aventis Deutschland GmbH, 65929 | Neue mit Benzylresten substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
| DE102006053636B4 (de) * | 2006-11-14 | 2008-09-18 | Sanofi-Aventis Deutschland Gmbh | Neue mit Cyclohexylresten substituierte 1,4-Benzothiepin-1,1-Dioxidderivate und deren Verwendung |
| ATE493992T1 (de) | 2006-11-14 | 2011-01-15 | Sanofi Aventis Deutschland | Neue 1,4-benzothiepin-1,1-dioxidderivate mit verbesserten eigenschaften, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| DE102006053637B4 (de) * | 2006-11-14 | 2011-06-30 | Sanofi-Aventis Deutschland GmbH, 65929 | Neue mit Fluor substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
| US9339480B2 (en) | 2008-11-26 | 2016-05-17 | Satiogen Pharmaceuticals, Inc. | Bile acid recycling inhibitors for treatment of obesity and diabetes |
| US20110294767A1 (en) | 2010-05-26 | 2011-12-01 | Satiogen Pharmaceuticals, Inc. | Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions |
| US9339543B2 (en) | 2011-10-12 | 2016-05-17 | Merck Sharp & Dohme Corp. | Pharmaceutical compositions that inhibit disproportionation |
| SG10201903512SA (en) | 2011-10-28 | 2019-05-30 | Lumena Pharmaceuticals Inc | Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver Diseases |
| DK2771003T3 (en) | 2011-10-28 | 2017-07-17 | Lumena Pharmaceuticals Llc | Bile acid recycling inhibitors for the treatment of pediatric cholestatic liver disease |
| CA2907214A1 (fr) | 2013-03-15 | 2014-09-18 | Lumena Pharmaceuticals, Inc. | Inhibiteurs de recyclage d'acide biliaire pour le traitement de l'sophage de barrett et du reflux gastrosophagien pathologique |
| JP2016514684A (ja) | 2013-03-15 | 2016-05-23 | ルメナ ファーマシューティカルズ エルエルシー | 原発性硬化性胆管炎および炎症性腸疾患の処置のための胆汁酸再循環阻害剤 |
| KR20150079373A (ko) | 2013-12-30 | 2015-07-08 | 한미약품 주식회사 | 에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제 |
| JP2022520121A (ja) | 2019-02-12 | 2022-03-28 | ミルム ファーマシューティカルズ インコーポレイテッド | 胆汁うっ滞を治療する方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2663336B1 (fr) | 1990-06-18 | 1992-09-04 | Adir | Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| CN1158290C (zh) | 1996-01-17 | 2004-07-21 | 诺沃挪第克公司 | 稠合1,2,4-噻二嗪与稠合1,4-噻嗪衍生物、其制备方法及用途 |
| JP3149958B2 (ja) | 1996-08-30 | 2001-03-26 | ノボ ノルディスク アクティーゼルスカブ | Ｇｌｐ―１誘導体 |
| IL142649A (en) | 1996-12-31 | 2004-12-15 | Reddy Research Foundation | Azole derivatives |
| DE19726167B4 (de) | 1997-06-20 | 2008-01-24 | Sanofi-Aventis Deutschland Gmbh | Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung |
| PL338013A1 (en) | 1997-07-16 | 2000-09-25 | Novo Nordisk As | Derivatives of condensed 1,2,4-thiadiazine, their production and application |
| CO4970713A1 (es) | 1997-09-19 | 2000-11-07 | Sanofi Synthelabo | Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen |
| US6221897B1 (en) * | 1998-06-10 | 2001-04-24 | Aventis Pharma Deutschland Gmbh | Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use |
| DE19825804C2 (de) * | 1998-06-10 | 2000-08-24 | Aventis Pharma Gmbh | 1,4-Benzothiepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| DE19845405C2 (de) | 1998-10-02 | 2000-07-13 | Aventis Pharma Gmbh | Arylsubstituierte Propanolaminderivate und deren Verwendung |
| EP1140187B1 (fr) * | 1998-12-23 | 2003-09-03 | G.D. Searle LLC. | Combinaisons d'un inhibiteur d'ibat et d'un inhibiteur de mtp utilisees dans le cadre de troubles cardio-vasculaires |
| GB9900416D0 (en) | 1999-01-08 | 1999-02-24 | Alizyme Therapeutics Ltd | Inhibitors |
| WO2000063208A1 (fr) | 1999-04-16 | 2000-10-26 | Novo Nordisk A/S | Imidazoles substitues, leur preparation et utilisation |
| WO2000066585A1 (fr) | 1999-04-30 | 2000-11-09 | Neurogen Corporation | Derives 9h-pyrimido[4,5-b]indoles: ligands specifiques de crf1 |
| GB9911863D0 (en) | 1999-05-21 | 1999-07-21 | Knoll Ag | Therapeutic agents |
| EP1194146B1 (fr) | 1999-06-18 | 2006-07-19 | Merck & Co., Inc. | Derives d'arylthiazolidinedione et d'aryloxazolidinedione |
| EP1204654B1 (fr) | 1999-07-29 | 2003-07-23 | Eli Lilly And Company | Benzofurylpiperazines: agonistes du recepteur 5-ht2c de la serotonine |
| EE200200095A (et) | 1999-09-01 | 2003-04-15 | Aventis Pharma Deutschland Gmbh | Sulfonüülkarboksamiidi derivaadid, nende kasutamine, ravim ja nende valmistamismeetod |
| DK1277736T3 (da) | 2000-04-28 | 2007-10-01 | Asahi Kasei Pharma Corp | Hidtil ukendte bicykliske forbindelser |
| BR0110638A (pt) | 2000-05-11 | 2003-03-25 | Bristol Myers Squibb Co | Análogos de tetraidroisoquinolina úteis como secretagogos de hormÈnio do crescimento |
| CA2410597A1 (fr) | 2000-05-30 | 2001-12-06 | Merck & Co., Inc. | Agonistes du recepteur de la melanocortine |
| IL156552A0 (en) | 2000-12-21 | 2004-01-04 | Aventis Pharma Gmbh | Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use |
-
2002
- 2002-08-09 HU HU0401318A patent/HUP0401318A3/hu unknown
- 2002-08-09 IL IL16047402A patent/IL160474A0/xx unknown
- 2002-08-09 BR BR0212031-3A patent/BR0212031A/pt not_active Withdrawn
- 2002-08-09 DE DE50212937T patent/DE50212937D1/de not_active Expired - Lifetime
- 2002-08-09 KR KR10-2004-7002440A patent/KR20040032937A/ko not_active Application Discontinuation
- 2002-08-09 AT AT02796213T patent/ATE411802T1/de not_active IP Right Cessation
- 2002-08-09 NZ NZ531293A patent/NZ531293A/en not_active IP Right Cessation
- 2002-08-09 EP EP02796213A patent/EP1425018B1/fr not_active Expired - Lifetime
- 2002-08-09 RU RU2004108119/15A patent/RU2297222C2/ru not_active IP Right Cessation
- 2002-08-09 RS YU11104A patent/RS11104A/sr unknown
- 2002-08-09 PL PL02366851A patent/PL366851A1/xx not_active Application Discontinuation
- 2002-08-09 WO PCT/EP2002/008908 patent/WO2003018024A1/fr active IP Right Grant
- 2002-08-09 CA CA002457976A patent/CA2457976A1/fr not_active Abandoned
- 2002-08-09 MX MXPA04001328A patent/MXPA04001328A/es active IP Right Grant
- 2002-08-09 CN CNA028163109A patent/CN1655792A/zh active Pending
- 2002-08-09 AU AU2002333373A patent/AU2002333373B2/en not_active Ceased
- 2002-08-09 JP JP2003522542A patent/JP2005501861A/ja active Pending
- 2002-08-09 OA OA1200400057A patent/OA12654A/en unknown
- 2002-08-16 PE PE2002000742A patent/PE20030361A1/es not_active Application Discontinuation
- 2002-08-20 UY UY27419A patent/UY27419A1/es unknown
- 2002-08-20 AR ARP020103125A patent/AR035285A1/es not_active Application Discontinuation
- 2002-08-20 HN HN2002000235A patent/HN2002000235A/es unknown
- 2002-08-20 PA PA20028553201A patent/PA8553201A1/es unknown
- 2002-08-22 US US10/225,841 patent/US20030158119A1/en not_active Abandoned
-
2003
- 2003-11-03 US US10/699,967 patent/US7179792B2/en not_active Expired - Lifetime
-
2004
- 2004-02-11 MA MA27524A patent/MA26317A1/fr unknown
- 2004-02-18 NO NO20040702A patent/NO20040702L/no not_active Application Discontinuation
- 2004-02-19 CO CO04014418A patent/CO5560550A2/es not_active Application Discontinuation
- 2004-02-20 HR HR20040171A patent/HRP20040171A2/xx not_active Application Discontinuation
- 2004-02-20 TN TNP2004000034A patent/TNSN04034A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1655792A (zh) | 2005-08-17 |
| JP2005501861A (ja) | 2005-01-20 |
| HUP0401318A2 (hu) | 2004-10-28 |
| US7179792B2 (en) | 2007-02-20 |
| TNSN04034A1 (en) | 2006-06-01 |
| ATE411802T1 (de) | 2008-11-15 |
| HRP20040171A2 (en) | 2004-10-31 |
| NO20040702L (no) | 2004-05-19 |
| WO2003018024A1 (fr) | 2003-03-06 |
| IL160474A0 (en) | 2004-07-25 |
| PE20030361A1 (es) | 2003-05-27 |
| RU2297222C2 (ru) | 2007-04-20 |
| HUP0401318A3 (en) | 2008-03-28 |
| DE50212937D1 (de) | 2008-12-04 |
| HN2002000235A (es) | 2003-02-18 |
| AR035285A1 (es) | 2004-05-05 |
| UY27419A1 (es) | 2003-04-30 |
| CO5560550A2 (es) | 2005-09-30 |
| US20030158119A1 (en) | 2003-08-21 |
| EP1425018A1 (fr) | 2004-06-09 |
| NZ531293A (en) | 2005-08-26 |
| US20040097424A1 (en) | 2004-05-20 |
| MXPA04001328A (es) | 2004-05-05 |
| OA12654A (en) | 2006-06-15 |
| RS11104A (en) | 2006-12-15 |
| EP1425018B1 (fr) | 2008-10-22 |
| RU2004108119A (ru) | 2005-04-10 |
| PA8553201A1 (es) | 2004-08-31 |
| KR20040032937A (ko) | 2004-04-17 |
| BR0212031A (pt) | 2004-08-03 |
| CA2457976A1 (fr) | 2003-03-06 |
| PL366851A1 (en) | 2005-02-07 |
| AU2002333373B2 (en) | 2006-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA26317A1 (fr) | Preparations combinees de derives de 1,1-dioxyde de 1,4-benzothiepine avec d'autres principes actifs et leur utilisation. | |
| EE05383B1 (et) | Polarlkarboksamiidhendid,ÁnendeÁvalmistamineÁjaÁkasutamineÁlipiiditasetÁalandavateÁtoimeainetenaÁningÁneidÁsisaldavÁfarmatseutilineÁkompositsioon | |
| CY1114594T1 (el) | Χρηση της [d-meala]3[etval]4-κυκλοσπορινης για την θεραπεια μολυνσης απο ηπατιτιδα c και φαρμακευτικη συνθεση που περιλαμβανει την εν λογω [d-meala]3[etval]4-κυκλοσπορινη | |
| ATE250924T1 (de) | Cyklosporin, hyaluronsäure und polysorbate enthaltenes augenarzneimittel | |
| PT1242425E (pt) | Compostos de n-(5,7-dimetoxi¬1,2,4|triazolo1,5-a|pirimidin-2-il) arilsulfonamida e sua utilizacao como herbicidas | |
| BR0112962B1 (pt) | Composições farmacêuticas compreendendo ácido hialurônico, ácido glicirretínico e polivinilpirrolidona, e uso desses compostos na preparação de medicamentos | |
| NO20032187L (no) | Heterocyklylalkylpiperidinderivater, deres fremstilling samt preparater inneholdende forbindelsene | |
| HUP0400832A3 (en) | New amidoalkyl-piperidine and amidoalkyl-piperazine derivatives, and pharmaceutical compositions containing such derivatives as active ingredients | |
| HUP0300653A3 (en) | Liquid composition formulations, containing herbicidal active ingredients preparing and use thereof | |
| FR2809730B1 (fr) | Derives de 1,4-diazabicyclo[3.2.2] nonanebenzoxazole, -benzothiazole et -benzimidazole, leur preparation et leur application therapeutique | |
| PL366855A1 (en) | Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof | |
| NO20025277L (no) | Farmasoytisk administreringsform for peptider, dens fremstilling samt anvendelse | |
| DK1228097T3 (da) | Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge | |
| AU2002333373A1 (en) | Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof | |
| TR200301931T2 (tr) | Saç gelişiminde 3 konumundaki siklosporin türevlerinin kullanılması | |
| ITRM20030363A0 (it) | Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse. | |
| MXPA03001826A (es) | Derivados de arilpiperazina. | |
| DE60125232D1 (de) | Kleines säurelösliches sporenprotein und seine verwendungen | |
| SE0001916D0 (sv) | Novel formulation | |
| EA200000875A1 (ru) | Белки, взаимодействующие с каспазой-8 | |
| HK1057857A1 (en) | Oxidized proteins, their biological activity, and therapeutic and diagnostic measures, which are derived from the active mechanism, from the use of these proteins or from the inhibition thereof | |
| ITMI20000293A0 (it) | Derivati del 3,9-diazabiciclo [3.3.1]nonano ad attivita' analgesica | |
| AR026890A1 (es) | Composiciones de tenocitos, preparaciones y utilizaciones | |
| HRP20020071B1 (en) | Pharmaceutical composition and preparation thereof | |
| HUP9904178A2 (hu) | 4-Bróm-1-metil-5-trifluor-metil-3-(2-fluor-4-klór-5-izopropoxi-karbonil-fenil)-pirazol alapú herbicid készítmények |